A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.

F.E. Stuurman, M.P.J.K. Lolkema, A.D. Huitema, P.M. Soetekouw, H. Rosing, H. Rolfe, P. Kaur, J.H. Beijnen, H. van Tinteren, E.E. Voest, J.H.M. Schellens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)878-883
Number of pages6
JournalJournal of Clinical Pharmacology
Issue number8
Publication statusPublished - 2013

Cite this